We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genetic Mutation Identified in Childhood Brain Disorder

By LabMedica International staff writers
Posted on 21 Aug 2018
Print article
Image: A comparison of an unaffected brain and an affected brain with pachygyria (Photo courtesy of Case Western Reserve University School of Medicine).
Image: A comparison of an unaffected brain and an affected brain with pachygyria (Photo courtesy of Case Western Reserve University School of Medicine).
Pachygyria is characterized by abnormal movement of brain nerve cells, known as neurons, during development of the brain and nervous system and is caused by a breakdown in the fetal neuronal migration process due to genetic or possibly environmental influences.

During normal embryonic growth, immature cells that later develop into specialized nerve cells (neurons) normally migrate to the brain's surface, making several layers of cells. When this process is impaired, the cells do not migrate to their locations, resulting in too few cell layers and absence (agyria) or incomplete development (pachygyria) of gyri.

A team of global genetics experts led by those at Case Western Reserve University Medical School (Cleveland, OH, USA) have discovered a genetic mutation and the faulty development process it triggers, causing a debilitating brain-based disorder in children, known as pachygyria. The scientists used genetic sequencing to study three families affected by the disease, and discovered that children with pachygyria have a mutation in both copies of the alpha-N-catenin gene (CTNNA2), each alteration coming from one parent. The mutation leads to loss of CTNNA2, which the team then showed affected how nerve cells travel from their source of origin in the developing brain to their concluding destination in what eventually becomes the neocortex, a process called neuronal migration.

The investigators found that when CTNNA2 is absent due to genetic mutation, excessive amounts of Actin-Related Proteins (ARP2/3) bind to actin, ultimately disrupting the mechanisms needed for appropriate migrating and branching out of nerve cells. Specifically, resultants ARP2/3 over-activity leads to excessive branching, which impairs neuron growth and stability. The finding raises the possibility of genetic engineering through techniques such as CRISPR-Cas9.

In addition to uncovering a key gene responsible for pachygyria and describing how its mechanisms operate, the scientists discovered a variation of the condition. Typically in cases of pachygyria, either the front or back of the brain displays smooth, non-wrinkled brain surface features. In cases of normal brain development, these areas are convoluted, resembling cauliflower in appearance. In the three families studied, they discovered that both the front and back of the brain were smooth.

The authors concluded that their findings identify CTNNA2 as the first catenin family member with biallelic mutations in humans, causing a new pachygyria syndrome linked to actin regulation, and uncover a key factor involved in ARP2/3 repression in neurons. Ashleigh E. Schaffer, PhD, an assistant professor of genetics and lead author of the study, said, “Our finding that alpha-N-catenin mutations cause pachygyria is an important step in understanding how neuronal development is regulated. The fact that we found this unique feature of back and front smooth brain led us to conclude that a new gene, not previously linked to pachygyria, is responsible. This turned out to be the case,” The study was published on July 16, 2018, in the journal Nature Genetics.

Related Links:
Case Western Reserve University Medical School

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.